Author:
Hao Han,Haas Michael J.,Wu Rongling,Gragnoli Claudia
Publisher
Springer Science and Business Media LLC
Reference62 articles.
1. Van Cauter, E., Spiegel, K., Tasali, E. & Leproult, R. Metabolic consequences of sleep and sleep loss. Sleep Med 9 Suppl 1, S23–28, S1389-9457(08)70013-310.1016/S1389-9457(08)70013-3 (2008).
2. Depner, C. M., Stothard, E. R. & Wright, K. P., Jr. Metabolic consequences of sleep and circadian disorders. Current diabetes reports 14, 507, 10.1007/s11892-014-0507-z (2014).
3. Cho, E. H., Lee, H., Ryu, O. H., Choi, M. G. & Kim, S. W. Sleep disturbances and glucoregulation in patients with type 2 diabetes. Journal of Korean medical science 29, 243-247, 10.3346/jkms.2014.29.2.243 (2014).
4. Iyer, S. R. Sleep and type 2 diabetes mellitus- clinical implications. The Journal of the Association of Physicians of India 60, 42–47 (2012).
5. She, M. et al. Piromelatine, a novel melatonin receptor agonist, stabilizes metabolic profiles and ameliorates insulin resistance in chronic sleep restricted rats. Eur J Pharmacol 727, 60–65, 10.1016/j.ejphar.2014.01.037 (2014).
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献